Evidence map›Paper›PMID 36651455›Full record

ArticleMemorias do Instituto Oswaldo Cruz2023

Raising the suspicion of a non-autochthonous infection: identification of Leishmania guyanensis from Costa Rica exhibits a Leishmaniavirus related to Brazilian north-east and French Guiana viral genotypes.

Carlos Mata-Somarribas, José Quesada-López, María F Matamoros, César Cervantes-Gómez, Annia Mejía, Karen Chacón, Ivannia Bendig, Roger Campos, Raphael Quesada-Morera, Lilian Motta Cantanhêde and 2 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Journal of parasitology research · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Carlos Mata-SomarribasInstituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, Centro Nacional de Referencia de Parasitología, Cartago, Costa Rica.ORCID http://orcid.org/0000-0001-7650-5388
José Quesada-LópezCaja Costarricense de Seguro Social, Área de Salud Santa Rosa de Pocosol, Alajuela, Costa Rica.
María F MatamorosCaja Costarricense de Seguro Social, Hospital Escalante Pradilla, San José, Costa Rica.
César Cervantes-GómezCaja Costarricense de Seguro Social, Hospital William Allen, Cartago, Costa Rica.
Annia MejíaCaja Costarricense de Seguro Social, Área de Salud Florencia, Alajuela, Costa Rica.
Karen ChacónCaja Costarricense de Seguro Social, Hospital Ciudad Neily, Puntarenas, Costa Rica.
Ivannia BendigCaja Costarricense de Seguro Social, Hospital de Guápiles, Limón, Costa Rica.
Roger CamposCaja Costarricense de Seguro Social, Área de Salud Matina, Limón, Costa Rica.
Raphael Quesada-MoreraCaja Costarricense de Seguro Social, Área de Salud Talamanca, Limón, Costa Rica.
Lilian Motta CantanhêdeFiocruz-Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Pesquisa em Leishmanioses, Rio de Janeiro, RJ, Brasil.
Luiza de Oliveira R PereiraFiocruz-Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Pesquisa em Leishmanioses, Rio de Janeiro, RJ, Brasil.
Elisa CupolilloFiocruz-Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Pesquisa em Leishmanioses, Rio de Janeiro, RJ, Brasil.
Costa Rican Department of Social Security · CRFundação Oswaldo Cruz · BRInstituto Costarricense de Investigación y Enseñanza en Nutrición y Salud · CR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCosta Rica has a history of neglecting prevention, control and research of leishmaniasis, including limited understanding on Leishmania species causing human disease across the country and a complete lack of knowledge on the Leishmania RNA virus, described as a factor linked to the worsening and metastasis of leishmanial lesions.

objectivesThe aim of this work was to describe a case of cutaneous leishmaniasis by Leishmania (Viannia) guyanensis, bearing infection with Leishmaniavirus 1 (LRV1) in Costa Rica, raising the suspicion of imported parasites in the region.

methodsThe Leishmania strain was previously identified by routine hsp70 polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in Costa Rica and subsequently characterised by isoenzyme electrophoresis and Sanger sequencing in Brazil. Screening for LRV1 was conducted with a dual RT-PCR approach and sequencing of the fragment obtained.

findingsSince 2016 Costa Rica performs Leishmania isolation and typing as part of its epidemiological surveillance activities. Amongst 113 strains typed until 2019, only one was characterised as a L. (V.) guyanensis, corresponding to the first confirmed report of this species in the country. Interestingly, the same strain tested positive for LRV1. Sequencing of the viral orf1 and 2, clustered this sample with other LRV1 genotypes of South American origin, from the Northeast of Brazil and French Guiana. MAIN

conclusionThe unique characteristics of this finding raised the suspicion that it was not an autochthonous strain. Notwithstanding its presumed origin, this report points to the occurrence of said endosymbiont in Central American Leishmania strains. The possibility of its local dispersion represents one more challenge faced by regional health authorities in preventing and controlling leishmaniasis.

Indexed as

Leishmania guyanensisLeishmaniasis, CutaneousLeishmaniavirusBrazilCosta RicaFrench GuianaGenotypeHumans

Identifiers

PMID36651455
PMCPMC9870268
OpenAlexW4316649867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.